Publication | Open Access
Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Combination Therapy in Patients With Coronavirus Disease 2019 and Primary Antibody Deficiency
13
Citations
9
References
2021
Year
The SARS-CoV-2 mAbs treatment was effective and well tolerated in patients with primary antibody defects.
| Year | Citations | |
|---|---|---|
Page 1
Page 1